<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02306278</url>
  </required_header>
  <id_info>
    <org_study_id>ky2013-008-01</org_study_id>
    <nct_id>NCT02306278</nct_id>
  </id_info>
  <brief_title>The Effects of Gabapentin Premedication on Neurosurgery</brief_title>
  <official_title>The Effects of Gabapentin Premedication on Postoperative Pain,Nausea,Vomiting and Sedation in Patients Undergoing Neurosurgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is to observe the effects of gabapentin premedication on postoperative
      pain,vomiting and nausea in patients undergoing neurosurgery. 100 neurosurgical patients are
      randomized into groups gabapentin(GG) or placebo(GP). Patients are given gabapentin or
      placebo orally the night before operation day and 2hours before surgery,respectively.The
      investigators hypothesized that lower incidence of postoperative pain,vomiting and nausea be
      observed in GG than GP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a random, double-blind study. In GG, patients are given gabapentin 600mg orally at
      the night and 2hours before surgery, respectively. In PG, vitamine pills are given
      instead.Total intravenous anesthesia is applied for all patients. 1hour, 2hours,1day, 2days,
      3months and 6months after surgery, patients are evaluated for pain (VAS) and incidence of
      PONV. In addition,Glasgow Score, Ramsay Score and other gabapentin-related effects, such as
      somnolence,dizzy or dry mouth are also observed.The incidence of persistent pain and
      neuropathic pain was assessed at the 3-mo and 6-mo postoperative evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 14, 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Premedication gabapentin can decrease pain in early postoperative period</measure>
    <time_frame>24 hour after extubation</time_frame>
    <description>postoperative pain scores(Visual Analogue Scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Premedication gabapentin can limit the development of persistent pain and neuropathic pain.</measure>
    <time_frame>3-mos and 6-mos after surgery</time_frame>
    <description>postoperative pain scores(Visual Analogue Scale) and the Leeds assessment of neuropathic symptoms and signs (LANSS) Pain Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative gabapentin can lead to a decrease incidence of PONV</measure>
    <time_frame>1 hour,2 hours,1day,2 days after surgery</time_frame>
    <description>Incidence of PONV</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The gabapentin-related effects on neurosurgical patients</measure>
    <time_frame>1 hour,2 hours,1day,2 days after surgery</time_frame>
    <description>Glasgow Score, Ramsay Score , somnolence,dizzy or dry mouth</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">122</enrollment>
  <condition>Cerebral Tumor</condition>
  <arm_group>
    <arm_group_label>vitamin capsules</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>vitamin capsules orally at the night before operation and 2 hours before surgery,respectively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gabapentin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>gabapentin 600mg orally at the night before operation and 2 hours before surgery,respectively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gabapentin</intervention_name>
    <description>gabapentin capsules 0.3g</description>
    <arm_group_label>gabapentin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitamin capsules</intervention_name>
    <description>vitamin B</description>
    <arm_group_label>vitamin capsules</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 years old, ASA physical status I or II, BMI&lt;30

          -  Scheduled for elective craniotomy

          -  Cooperative and given informed consent in person

        Exclusion Criteria:

          -  History of mental or psychiatric disorders

          -  Pregnant or lactating female

          -  History of systemic malignant tumor or diabetes

          -  Previously treated with this protocol or participated in another experimental study
             within previous 30 days

          -  Suspected history of allergic reaction or intolerance to gabapentin or other
             anesthetic agents in this study

          -  History of alcohol abuse and/or drug abuse within previous one year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ru Quan Han, chief</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology,Beijing Tiantan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2014</study_first_submitted>
  <study_first_submitted_qc>December 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2014</study_first_posted>
  <last_update_submitted>October 13, 2017</last_update_submitted>
  <last_update_submitted_qc>October 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Wei Zhang</investigator_full_name>
    <investigator_title>attending doctor</investigator_title>
  </responsible_party>
  <keyword>gabapentin</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>vomiting</keyword>
  <keyword>nausea</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

